Skip to content
value.today

BioMatrix Holdings, L.L.C.

🇺🇸 Weston, Florida, USAHealth CareFounded 2016
Total raised
$80 M
1 round on record
Latest round
$80 M
Nov 2016
First round on record
Nov 2016
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of BioMatrix Holdings, L.L.C.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2016$80 MNo. 1$50 to $250 million

BioMatrix Holdings, L.L.C.: Raise no. 1, Nov 2016

Investors in this round

9 investors had bought by the notice of Dec 2, 2016: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$80 M of $80 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Bruce Morgan Greenberg · Executive Officer, Director · Chief Executive Officer and Manager
  • Darrin Peter Carrico · Executive Officer · Senior Vice President of Digital Health & Managed Care
  • David Peter Mccormick · Executive Officer · Chief Clinical Officer
  • Joseph Peter Ziegler · Executive Officer · Chief Financial Officer and Secretary
  • Saverio Peter Rafanelli · Executive Officer · President and Chief Operating Officer
  • Todd Peter Krasinsky · Executive Officer · Senior Vice President of Transplant Therapy
  • Daniel Morgan Jinich · Director · Manager
  • Joe Morgan Davis · Director · Manager
  • John Morgan Barr · Director · Manager
  • L. Peter Smith · Director · Manager
  • Pat Morgan Keefe · Director · Manager
  • Tracy Morgan Finn · Director · Manager and Executive Chairman

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bruce Greenberg, Chief Executive Officer. Newest notice filed Dec 2, 2016. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • BioMatrix Holdings, L.L.C. chose not to state its revenue in its newest notice of a funding round (Dec 2016).

    SEC Form D · Dec 2016

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Dec 2016

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of BioMatrix Holdings, L.L.C. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by BioMatrix Holdings, L.L.C.
NameRoleNamed in
Bruce Morgan GreenbergChief Executive Officer and ManagerDec 2016
Darrin Peter CarricoSenior Vice President of Digital Health & Managed CareDec 2016
David Peter MccormickChief Clinical OfficerDec 2016
Joseph Peter ZieglerChief Financial Officer and SecretaryDec 2016
Saverio Peter RafanelliPresident and Chief Operating OfficerDec 2016
Todd Peter KrasinskySenior Vice President of Transplant TherapyDec 2016
Bruce Morgan GreenbergChief Executive Officer and ManagerDec 2016
Daniel Morgan JinichManagerDec 2016
Joe Morgan DavisManagerDec 2016
John Morgan BarrManagerDec 2016
L. Peter SmithManagerDec 2016
Pat Morgan KeefeManagerDec 2016
Tracy Morgan FinnManager and Executive ChairmanDec 2016